| 1. Sum PE, Petersen P.. (1999) Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936., 9 (10): [PMID:10360756] [10.1016/s0960-894x(99)00216-4] |
| 2. Sum PE, Lee VJ, Testa RT, Hlavka JJ, Ellestad GA, Bloom JD, Gluzman Y, Tally FP.. (1994) Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines., 37 (1): [PMID:8289194] [10.1021/jm00027a023] |
| 3. Koza DJ, Nsiah YA.. (2002) Synthesis and biological evaluation of 9-substituted tetracycline derivatives., 12 (16): [PMID:12127528] [10.1016/s0960-894x(02)00369-4] |
| 4. Nelson ML, Park BH, Andrews JS, Georgian VA, Thomas RC, Levy SB.. (1993) Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines., 36 (3): [PMID:8426364] [10.1021/jm00055a008] |
| 5. Chu DT, Plattner JJ, Katz L.. (1996) New directions in antibacterial research., 39 (20): [PMID:8831751] [10.1021/jm960294s] |
| 6. Colmenarejo G, Alvarez-Pedraglio A, Lavandera JL.. (2001) Cheminformatic models to predict binding affinities to human serum albumin., 44 (25): [PMID:11728183] [10.1021/jm010960b] |
| 7. Garcia-Domenech R, de Gregorio Alapont C, de Julian-Ortiz J, Galvez J, Popa L. (1997) Molecular connectivity to find -blockers with low toxicity, 7 (5): [10.1016/S0960-894X(97)00046-2] |
| 8. Sum PE, Ross AT, Petersen PJ, Testa RT.. (2006) Synthesis and antibacterial activity of 9-substituted minocycline derivatives., 16 (2): [PMID:16246559] [10.1016/j.bmcl.2005.09.078] |
| 9. Hawley JS, Murray CK, Griffith ME, McElmeel ML, Fulcher LC, Hospenthal DR, Jorgensen JH.. (2007) Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel., 51 (1): [PMID:17043112] [10.1128/aac.00858-06] |
| 10. Weigel LM, Donlan RM, Shin DH, Jensen B, Clark NC, McDougal LK, Zhu W, Musser KA, Thompson J, Kohlerschmidt D, Dumas N, Limberger RJ, Patel JB.. (2007) High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm., 51 (1): [PMID:17074796] [10.1128/aac.00576-06] |
| 11. Raad I, Hanna H, Dvorak T, Chaiban G, Hachem R.. (2007) Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm., 51 (1): [PMID:17074799] [10.1128/aac.00154-06] |
| 12. Zhou J, Chen Y, Tabibi S, Alba L, Garber E, Saiman L.. (2007) Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis., 51 (3): [PMID:17158942] [10.1128/aac.00954-06] |
| 13. Cercenado E, Marín M, Sánchez-Martínez M, Cuevas O, Martínez-Alarcón J, Bouza E.. (2007) In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods., 51 (3): [PMID:17194827] [10.1128/aac.01102-06] |
| 14. Izdebski R, Sadowy E, Fiett J, Grzesiowski P, Gniadkowski M, Hryniewicz W.. (2007) Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland., 51 (4): [PMID:17210772] [10.1128/aac.01384-06] |
| 15. Cho SH, Warit S, Wan B, Hwang CH, Pauli GF, Franzblau SG.. (2007) Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis., 51 (4): [PMID:17210775] [10.1128/aac.00055-06] |
| 16. Giacometti A, Cirioni O, Riva A, Kamysz W, Silvestri C, Nadolski P, Della Vittoria A, Łukasiak J, Scalise G.. (2007) In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci., 51 (4): [PMID:17220421] [10.1128/aac.00666-06] |
| 17. Pucci MJ, Cheng J, Podos SD, Thoma CL, Thanassi JA, Buechter DD, Mushtaq G, Vigliotti GA, Bradbury BJ, Deshpande M.. (2007) In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens., 51 (4): [PMID:17242152] [10.1128/aac.01315-06] |
| 18. Chen CP, Zeiger AR, Wickstrom E.. (2007) Bactericidal activity of extended 9-glycyl-amido-minocyclines., 17 (23): [PMID:17933534] [10.1016/j.bmcl.2007.09.077] |
| 19. Sriram D, Yogeeswari P, Senchani G, Banerjee D.. (2007) Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase., 17 (8): [PMID:17376679] [10.1016/j.bmcl.2006.11.055] |
| 20. Moda TL, Montanari CA, Andricopulo AD.. (2007) Hologram QSAR model for the prediction of human oral bioavailability., 15 (24): [PMID:17870541] [10.1016/j.bmc.2007.08.060] |
| 21. Hirokawa Y, Kinoshita H, Tanaka T, Nakata K, Kitadai N, Fujimoto K, Kashimoto S, Kojima T, Kato S.. (2008) Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens., 51 (7): [PMID:18330977] [10.1021/jm8000136] |
| 22. Knuckley B, Luo Y, Thompson PR.. (2008) Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors., 16 (2): [PMID:17964793] [10.1016/j.bmc.2007.10.021] |
| 23. Yamazaki T, Sasaki T, Takahata M.. (2007) Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae., 51 (6): [PMID:17387152] [10.1128/aac.01561-06] |
| 24. Scheetz MH, Qi C, Warren JR, Postelnick MJ, Zembower T, Obias A, Noskin GA.. (2007) In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii., 51 (5): [PMID:17307973] [10.1128/aac.01099-06] |
| 25. Peleg AY, Adams J, Paterson DL.. (2007) Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii., 51 (6): [PMID:17420217] [10.1128/aac.01198-06] |
| 26. Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sherertz R, Hachem R.. (2007) Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm., 51 (5): [PMID:17353249] [10.1128/aac.00350-06] |
| 27. Santana L, González-Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, Orallo F.. (2008) Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors., 51 (21): [PMID:18834112] [10.1021/jm800656v] |
| 28. Nikodemova M, Watters JJ, Jackson SJ, Yang SK, Duncan ID.. (2007) Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII., 282 (20): [PMID:17395590] [10.1074/jbc.m611907200] |
| 29. Tuckman M, Petersen PJ, Howe AY, Orlowski M, Mullen S, Chan K, Bradford PA, Jones CH.. (2007) Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline., 51 (9): [PMID:17620376] [10.1128/aac.00625-07] |
| 30. Wang H, Guo P, Sun H, Wang H, Yang Q, Chen M, Xu Y, Zhu Y.. (2007) Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals., 51 (11): [PMID:17846127] [10.1128/aac.01259-06] |
| 31. Périchon B, Courvalin P, Galimand M.. (2007) Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli., 51 (7): [PMID:17470656] [10.1128/aac.00143-07] |
| 32. Chow VC, Hawkey PM, Chan EW, Chin ML, Au TK, Fung DK, Chan RC.. (2007) High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus., 51 (7): [PMID:17371822] [10.1128/aac.00603-06] |
| 33. Hawley JS, Murray CK, Jorgensen JH.. (2007) Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex., 51 (12): [PMID:17876007] [10.1128/aac.01115-07] |
| 34. Morozumi M, Iwata S, Hasegawa K, Chiba N, Takayanagi R, Matsubara K, Nakayama E, Sunakawa K, Ubukata K, Acute Respiratory Diseases Study Group.. (2008) Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia., 52 (1): [PMID:17954691] [10.1128/aac.00779-07] |
| 35. Damier-Piolle L, Magnet S, Brémont S, Lambert T, Courvalin P.. (2008) AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii., 52 (2): [PMID:18086852] [10.1128/aac.00732-07] |
| 36. Dégrange S, Renaudin H, Charron A, Bébéar C, Bébéar CM.. (2008) Tetracycline resistance in Ureaplasma spp. and Mycoplasma hominis: prevalence in Bordeaux, France, from 1999 to 2002 and description of two tet(M)-positive isolates of M. hominis susceptible to tetracyclines., 52 (2): [PMID:18025113] [10.1128/aac.00960-07] |
| 37. Tam KY, Avdeef A, Tsinman O, Sun N.. (2010) The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability., 53 (1): [PMID:19947605] [10.1021/jm901421c] |
| 38. Varma MV, Obach RS, Rotter C, Miller HR, Chang G, Steyn SJ, El-Kattan A, Troutman MD.. (2010) Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination., 53 (3): [PMID:20070106] [10.1021/jm901371v] |
| 39. Reinke AA, Seh HY, Gestwicki JE.. (2009) A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta., 19 (17): [PMID:19640715] [10.1016/j.bmcl.2009.07.082] |
| 40. Coyne S, Guigon G, Courvalin P, Périchon B.. (2010) Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray., 54 (1): [PMID:19884373] [10.1128/aac.01037-09] |
| 41. Prado-Prado FJ, García-Mera X, González-Díaz H.. (2010) Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species., 18 (6): [PMID:20185316] [10.1016/j.bmc.2010.01.068] |
| 42. Robledo IE, Aquino EE, Santé MI, Santana JL, Otero DM, León CF, Vázquez GJ.. (2010) Detection of KPC in Acinetobacter spp. in Puerto Rico., 54 (3): [PMID:20038618] [10.1128/aac.00899-09] |
| 43. Hentschke M, Christner M, Sobottka I, Aepfelbacher M, Rohde H.. (2010) Combined ramR mutation and presence of a Tn1721-associated tet(A) variant in a clinical isolate of Salmonella enterica serovar Hadar resistant to tigecycline., 54 (3): [PMID:20028818] [10.1128/aac.00993-09] |
| 44. Hernould M, Gagné S, Fournier M, Quentin C, Arpin C.. (2008) Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance., 52 (4): [PMID:18268083] [10.1128/aac.01052-07] |
| 45. Salas C, Calvo J, Martínez-Martínez L.. (2008) Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes., 52 (4): [PMID:18227183] [10.1128/aac.01129-07] |
| 46. Moland ES, Craft DW, Hong SG, Kim SY, Hachmeister L, Sayed SD, Thomson KS.. (2008) In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy., 52 (8): [PMID:18519722] [10.1128/aac.01581-07] |
| 47. Wolff BJ, Thacker WL, Schwartz SB, Winchell JM.. (2008) Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis., 52 (10): [PMID:18644962] [10.1128/aac.00582-08] |
| 48. Abril C, Brodard I, Perreten V.. (2010) Two novel antibiotic resistance genes, tet(44) and ant(6)-Ib, are located within a transferable pathogenicity island in Campylobacter fetus subsp. fetus., 54 (7): [PMID:20479200] [10.1128/aac.00304-10] |
| 49. Zapor MJ, Barber M, Summers A, Miller GH, Feeney LA, Eberly LE, Wortmann G.. (2010) In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center., 54 (7): [PMID:20404121] [10.1128/aac.01173-09] |
| 50. Obach RS, Lombardo F, Waters NJ.. (2008) Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds., 36 (7): [PMID:18426954] [10.1124/dmd.108.020479] |
| 51. del Pozo JL, Rouse MS, Mandrekar JN, Sampedro MF, Steckelberg JM, Patel R.. (2009) Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms., 53 (1): [PMID:18725436] [10.1128/aac.00237-08] |
| 52. Jones CH, Tuckman M, Keeney D, Ruzin A, Bradford PA.. (2009) Characterization and sequence analysis of extended-spectrum-{beta}-lactamase-encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials., 53 (2): [PMID:19015360] [10.1128/aac.00883-08] |
| 53. Cui L, Neoh HM, Shoji M, Hiramatsu K.. (2009) Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus., 53 (3): [PMID:19124662] [10.1128/aac.01173-08] |
| 54. Arroyo LA, Mateos I, González V, Aznar J.. (2009) In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group., 53 (3): [PMID:19075049] [10.1128/aac.01097-08] |
| 55. Woodford N, Carattoli A, Karisik E, Underwood A, Ellington MJ, Livermore DM.. (2009) Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone., 53 (10): [PMID:19687243] [10.1128/aac.00688-09] |
| 56. Hamasuna R, Jensen JS, Osada Y.. (2009) Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR., 53 (11): [PMID:19738019] [10.1128/aac.00724-09] |
| 57. Bowker KE, Caspers P, Gaucher B, MacGowan AP.. (2009) In vitro activities of three new dihydrofolate reductase inhibitors against clinical isolates of gram-positive bacteria., 53 (11): [PMID:19738027] [10.1128/aac.00845-09] |
| 58. Nakao K, Tanaka K, Ichiishi S, Mikamo H, Shibata T, Watanabe K.. (2009) Susceptibilities of 23 Desulfovibrio isolates from humans., 53 (12): [PMID:19786606] [10.1128/aac.00630-09] |
| 59. Miller CH, Nisa S, Dempsey S, Jack C, O'Toole R.. (2009) Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria., 53 (12): [PMID:19786608] [10.1128/aac.00803-09] |
| 60. Biedenbach DJ, Castanheira M, Jones RN.. (2010) Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection., 54 (9): [PMID:20625152] [10.1128/aac.01812-09] |
| 61. Bowker KE, Noel AR, Macgowan AP.. (2008) Pharmacodynamics of minocycline against Staphylococcus aureus in an in vitro pharmacokinetic model., 52 (12): [PMID:18519719] [10.1128/aac.00922-07] |
| 62. Banères-Roquet F, Gualtieri M, Villain-Guillot P, Pugnière M, Leonetti JP.. (2009) Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions., 53 (4): [PMID:19164148] [10.1128/aac.00971-08] |
| 63. Clark C, Ednie LM, Lin G, Smith K, Kosowska-Shick K, McGhee P, Dewasse B, Beachel L, Caspers P, Gaucher B, Mert G, Shapiro S, Appelbaum PC.. (2009) Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugs., 53 (4): [PMID:19188385] [10.1128/aac.01619-08] |
| 64. Ishikawa C, Tsuda T, Konishi H, Nakagawa N, Yamanishi K.. (2009) Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes., 53 (5): [PMID:19258275] [10.1128/aac.01540-08] |
| 65. Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, Wang M.. (2009) Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China., 53 (5): [PMID:19273684] [10.1128/aac.01684-08] |
| 66. Long F, Rouquette-Loughlin C, Shafer WM, Yu EW.. (2008) Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli., 52 (9): [PMID:18591276] [10.1128/aac.00475-08] |
| 67. Wehmeier C, Schuster S, Fähnrich E, Kern WV, Bohnert JA.. (2009) Site-directed mutagenesis reveals amino acid residues in the Escherichia coli RND efflux pump AcrB that confer macrolide resistance., 53 (1): [PMID:18936189] [10.1128/aac.00921-08] |
| 68. Morvan A, Moubareck C, Leclercq A, Hervé-Bazin M, Bremont S, Lecuit M, Courvalin P, Le Monnier A.. (2010) Antimicrobial resistance of Listeria monocytogenes strains isolated from humans in France., 54 (6): [PMID:20385859] [10.1128/aac.01557-09] |
| 69. Bohnert JA, Karamian B, Nikaido H.. (2010) Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates., 54 (9): [PMID:20606071] [10.1128/aac.00620-10] |
| 70. Ruiz C, Levy SB.. (2010) Many chromosomal genes modulate MarA-mediated multidrug resistance in Escherichia coli., 54 (5): [PMID:20211899] [10.1128/aac.01420-09] |
| 71. Clark RB, He M, Fyfe C, Lofland D, O'Brien WJ, Plamondon L, Sutcliffe JA, Xiao XY.. (2011) 8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents., 54 (5): [PMID:21302930] [10.1021/jm1015389] |
| 72. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A.. (2010) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species., 23 (1): [PMID:20014752] [10.1021/tx900326k] |
| 73. Matthews EJ, Kruhlak NL, Weaver JL, Benz RD, Contrera JF.. (2004) Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling., 1 (4): [PMID:16472241] [10.2174/1570163043334794] |
| 74. Sun C, Hunt DK, Clark RB, Lofland D, O'Brien WJ, Plamondon L, Xiao XY.. (2011) Synthesis and antibacterial activity of pentacyclines: a novel class of tetracycline analogs., 54 (11): [PMID:21500832] [10.1021/jm1015395] |
| 75. Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W.. (2011) FDA-approved drug labeling for the study of drug-induced liver injury., 16 (15-16): [PMID:21624500] [10.1016/j.drudis.2011.05.007] |
| 76. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W.. (2011) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)., 7 (12): [PMID:22194678] [10.1371/journal.pcbi.1002310] |
| 77. Deng S, Zhang BJ, Wang CY, Tian Y, Yao JH, An L, Huang SS, Peng JY, Liu KX, Ma XC.. (2012) Microbial transformation of deoxyandrographolide and their inhibitory activity on LPS-induced NO production in RAW 264.7 macrophages., 22 (4): [PMID:22264489] [10.1016/j.bmcl.2011.12.122] |
| 78. Sakatis MZ, Reese MJ, Harrell AW, Taylor MA, Baines IA, Chen L, Bloomer JC, Yang EY, Ellens HM, Ambroso JL, Lovatt CA, Ayrton AD, Clarke SE.. (2012) Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., 25 (10): [PMID:22931300] [10.1021/tx300075j] |
| 79. Babu E, Takeda M, Narikawa S, Kobayashi Y, Yamamoto T, Cha SH, Sekine T, Sakthisekaran D, Endou H.. (2002) Human organic anion transporters mediate the transport of tetracycline., 88 (1): [PMID:11855680] [10.1254/jjp.88.69] |
| 80. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
| 81. PubChem BioAssay data set, |
| 82. Brunhofer G, Fallarero A, Karlsson D, Batista-Gonzalez A, Shinde P, Gopi Mohan C, Vuorela P.. (2012) Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine., 20 (22): [PMID:23062825] [10.1016/j.bmc.2012.09.040] |
| 83. PubChem BioAssay data set, |
| 84. Sun Y, Liu D, Xi R, Wang X, Wang Y, Hou J, Zhang B, Wang C, Liu K, Ma X.. (2013) Microbial transformation of acetyl-11-keto-β-boswellic acid and their inhibitory activity on LPS-induced NO production., 23 (5): [PMID:23391590] [10.1016/j.bmcl.2012.12.086] |
| 85. Unpublished dataset, |
| 86. Cai G, Napolitano JG, McAlpine JB, Wang Y, Jaki BU, Suh JW, Yang SH, Lee IA, Franzblau SG, Pauli GF, Cho S.. (2013) Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain., 76 (11): [PMID:24224794] [10.1021/np400145u] |
| 87. Stoilova T, Colombo L, Forloni G, Tagliavini F, Salmona M.. (2013) A new face for old antibiotics: tetracyclines in treatment of amyloidoses., 56 (15): [PMID:23611039] [10.1021/jm400161p] |
| 88. Biour M, Ben Salem C, Chazouillères O, Grangé JD, Serfaty L, Poupon R.. (2004) [Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs]., 28 (8-9): [PMID:15646539] [10.1016/s0399-8320(04)95062-2] |
| 89. Kaiser M, Mäser P, Tadoori LP, Ioset JR, Brun R.. Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning, [10.6019/CHEMBL3392926] |
| 90. Ren S, Zeng J, Mei Y, Zhang JZ, Yan SF, Fei J, Chen L.. (2013) Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors., 41 (1): [PMID:23033255] [10.1124/dmd.112.048264] |
| 91. Tran TP, Vo DD, Di Giorgio A, Duca M.. (2015) Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting., 23 (17): [PMID:26264847] [10.1016/j.bmc.2015.07.062] |
| 92. Dahdouh E, Orgaz B, Gomez-Gil R, Mingorance J, Daoud Z, Suarez M, San Jose C. (2016) Patterns of biofilm structure and formation kinetics among Acinetobacter baumannii clinical isolates with different antibiotic resistance profiles, 7 (1): [10.1039/C5MD00377F] |
| 93. Abdeen S, Salim N, Mammadova N, Summers CM, Frankson R, Ambrose AJ, Anderson GG, Schultz PG, Horwich AL, Chapman E, Johnson SM.. (2016) GroEL/ES inhibitors as potential antibiotics., 26 (13): [PMID:27184767] [10.1016/j.bmcl.2016.04.089] |
| 94. WHO Anatomical Therapeutic Chemical Classification, |
| 95. Li N, Wang Y, Li X, Zhang H, Zhou D, Wang W, Li W, Zhang X, Li X, Hou Y, Meng D.. (2016) Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge., 26 (20): [PMID:27623545] [10.1016/j.bmcl.2016.08.094] |
| 96. Peng Y, Lou LL, Liu SF, Zhou L, Huang XX, Song SJ.. (2016) Antioxidant and anti-inflammatory neolignans from the seeds of hawthorn., 26 (22): [PMID:27765508] [10.1016/j.bmcl.2016.10.012] |
| 97. Tanaka SK, Steenbergen J, Villano S.. (2016) Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic., 24 (24): [PMID:27469981] [10.1016/j.bmc.2016.07.029] |
| 98. Zhou D, Zhang Y, Jiang Z, Hou Y, Jiao K, Yan C, Li N.. (2017) Biotransformation of isofraxetin-6-O-β-d-glucopyranoside by Angelica sinensis (Oliv.) Diels callus., 27 (2): [PMID:27919656] [10.1016/j.bmcl.2016.11.069] |
| 99. Vajs J, Proud C, Brozovic A, Gazvoda M, Lloyd A, Roper DI, Osmak M, Košmrlj J, Dowson CG.. (2017) Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis., 127 [PMID:28063354] [10.1016/j.ejmech.2016.12.060] |
| 100. Zhou D, Wei H, Jiang Z, Li X, Jiao K, Jia X, Hou Y, Li N.. (2017) Natural potential neuroinflammatory inhibitors from Alhagi sparsifolia Shap., 27 (4): [PMID:28073678] [10.1016/j.bmcl.2016.12.075] |
| 101. Lyu Y, Yang X, Goswami S, Gorityala BK, Idowu T, Domalaon R, Zhanel GG, Shan A, Schweizer F.. (2017) Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline., 60 (9): [PMID:28409644] [10.1021/acs.jmedchem.6b01742] |
| 102. Yang X, Goswami S, Gorityala BK, Domalaon R, Lyu Y, Kumar A, Zhanel GG, Schweizer F.. (2017) A Tobramycin Vector Enhances Synergy and Efficacy of Efflux Pump Inhibitors against Multidrug-Resistant Gram-Negative Bacteria., 60 (9): [PMID:28399372] [10.1021/acs.jmedchem.7b00156] |
| 103. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W.. (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans., 21 (4): [PMID:26948801] [10.1016/j.drudis.2016.02.015] |
| 104. Song Y, Pan L, Li W, Si Y, Zhou D, Zheng C, Hao X, Jia X, Jia Y, Shi M, Jia X, Li N, Hou Y.. (2017) Natural neuro-inflammatory inhibitors from Caragana turfanensis., 27 (20): [PMID:28911817] [10.1016/j.bmcl.2017.08.047] |
| 105. Gao C, Du Y, Wang X, Cao H, Lin B, Liu Y, Di X.. (2018) Hexahydrobenzophenanthridine alkaloids from Corydalis bungeana Turcz. and their anti-inflammatory activity., 28 (13): [PMID:29853329] [10.1016/j.bmcl.2018.05.039] |
| 106. Zhang GJ, Pan QM, Zhang YL, Liao HB, Yang YQ, Hou Y, Liang D.. (2018) Coumarinolignoids and Taraxerane Triterpenoids from Sapium discolor and Their Inhibitory Potential on Microglial Nitric Oxide Production., 81 (10): [PMID:30350995] [10.1021/acs.jnatprod.8b00585] |
| 107. Unpublished dataset, |
| 108. Katie Heiser, Peter F. McLean, Chadwick T. Davis, Ben Fogelson, Hannah B. Gordon, Pamela Jacobson, Brett Hurst, Ben Miller, Ronald W. Alfa, Berton A. Earnshaw, Mason L. Victors, Yolanda T. Chong, Imran S. Haque, Adeline S. Low, Christopher C. Gibson. (2020) Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2, [10.1101/2020.04.21.054387] |
| 109. Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.. (2019) Design of Trp-Rich Dodecapeptides with Broad-Spectrum Antimicrobial Potency and Membrane-Disruptive Mechanism., 62 (15): [PMID:31276398] [10.1021/acs.jmedchem.9b00288] |
| 110. Zhou D, Chen G, Ma YP, Wang CG, Lin B, Yang YQ, Li W, Koike K, Hou Y, Li N.. (2019) Isolation, Structural Elucidation, Optical Resolution, and Antineuroinflammatory Activity of Phenanthrene and 9,10-Dihydrophenanthrene Derivatives from Bletilla striata., 82 (8): [PMID:31415170] [10.1021/acs.jnatprod.9b00291] |
| 111. Garner AL, Lorenz DA, Sandoval J, Gallagher EE, Kerk SA, Kaur T, Menon A.. (2019) Tetracyclines as Inhibitors of Pre-microRNA Maturation: A Disconnection between RNA Binding and Inhibition., 10 (5): [PMID:31098005] [10.1021/acsmedchemlett.9b00091] |
| 112. Idowu T, Ammeter D, Rossong H, Zhanel GG, Schweizer F.. (2019) Homodimeric Tobramycin Adjuvant Repurposes Novobiocin as an Effective Antibacterial Agent against Gram-Negative Bacteria., 62 (20): [PMID:31557020] [10.1021/acs.jmedchem.9b00876] |
| 113. Gatadi S, Gour J, Shukla M, Kaul G, Kaul G, Dasgupta A, Madhavi YV, Chopra S, Nanduri S.. (2019) Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis., 175 [PMID:31096152] [10.1016/j.ejmech.2019.04.067] |
| 114. Rana P, Will Y, Nadanaciva S, Jones LH.. (2016) Development of a cell viability assay to assess drug metabolite structure-toxicity relationships., 26 (16): [PMID:27397500] [10.1016/j.bmcl.2016.06.088] |
| 115. Jacobs RT, Lunde CS, Freund YR, Hernandez V, Li X, Xia Y, Carter DS, Berry PW, Halladay J, Rock F, Stefanakis R, Easom E, Plattner JJ, Ford L, Johnston KL, Cook DAN, Clare R, Cassidy A, Myhill L, Tyrer H, Gamble J, Guimaraes AF, Steven A, Lenz F, Ehrens A, Frohberger SJ, Koschel M, Hoerauf A, Hübner MP, McNamara CW, Bakowski MA, Turner JD, Taylor MJ, Ward SA.. (2019) Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis., 62 (5): [PMID:30730745] [10.1021/acs.jmedchem.8b01854] |
| 116. Yang ZN, Su BJ, Wang YQ, Liao HB, Chen ZF, Liang D.. (2020) Isolation, Absolute Configuration, and Biological Activities of Chebulic Acid and Brevifolincarboxylic Acid Derivatives from Euphorbia hirta., 83 (4): [PMID:32141299] [10.1021/acs.jnatprod.9b00877] |
| 117. Xiao J, Song JY, Lin B, Li W, Yang YQ, Liu JY, Hou Y, Chen G, Li N.. (2020) Amide-Iminoate Isomerism in Antineuroinflammatory Isoquinoline Alkaloids from Stephania cepharantha., 83 (4): [PMID:32129063] [10.1021/acs.jnatprod.9b00483] |
| 118. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
| 119. (2018) An elisa-like assay for quantifying enzymatic activities of mono-adp-ribosyltransferases, |
| 120. Lopes AP, de Oliveira Castelo Branco RR, de Alcântara Oliveira FA, Campos MAS, de Carvalho Sousa B, Agostinho ÍRC, Gonzalez AGM, Rocha JA, Pinheiro REE, Araújo AR, Dos Santos Soares MJ.. (2021) Antimicrobial, modulatory, and antibiofilm activity of tt-farnesol on bacterial and fungal strains of importance to human health., 47 [PMID:34118413] [10.1016/j.bmcl.2021.128192] |
| 121. Zheng YK, Su BJ, Wang YQ, Wang HS, Liao HB, Liang D.. (2021) New Tyramine- and Aporphine-Type Alkamides with NO Release Inhibitory Activities from Piper puberulum., 84 (4.0): [PMID:33822610] [10.1021/acs.jnatprod.1c00055] |
| 122. Meenu MT, Kaul G, Shukla M, Radhakrishnan KV, Chopra S.. (2021) Cudraflavone C from Artocarpus hirsutus as a Promising Inhibitor of Pathogenic, Multidrug-Resistant S. aureus, Persisters, and Biofilms: A New Insight into a Rational Explanation of Traditional Wisdom., 84 (10.0): [PMID:34546736] [10.1021/acs.jnatprod.1c00578] |
| 123. Baidya SK, Banerjee S, Adhikari N, Jha T.. (2022) Selective Inhibitors of Medium-Size S1' Pocket Matrix Metalloproteinases: A Stepping Stone of Future Drug Discovery., 65 (16.0): [PMID:35969157] [10.1021/acs.jmedchem.1c01855] |
| 124. Hasriadi, Wasana PWD, Sritularak B, Vajragupta O, Rojsitthisak P, Towiwat P.. (2022) Batatasin III, a Constituent of Dendrobium scabrilingue, Improves Murine Pain-like Behaviors with a Favorable CNS Safety Profile., 85 (7.0): [PMID:35707966] [10.1021/acs.jnatprod.2c00376] |
| 125. Meenu MT, Kaul G, Akhir A, Shukla M, Radhakrishnan KV, Chopra S.. (2022) Developing the Natural Prenylflavone Artocarpin from Artocarpus hirsutus as a Potential Lead Targeting Pathogenic, Multidrug-Resistant Staphylococcus aureus, Persisters and Biofilms with No Detectable Resistance., 85 (10.0): [PMID:36222797] [10.1021/acs.jnatprod.2c00621] |
| 126. Kumar V, Islam A, Hassan MI, Ahmad F.. (2016) Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning., 121 [PMID:27372371] [10.1016/j.ejmech.2016.06.017] |
| 127. Sutherland JJ, Yonchev D, Fekete A, Urban L.. (2023) A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs., 14 (1): [PMID:37468498] [10.1038/s41467-023-40064-9] |
